Hire an Advanced Robo-Advisor to Trade ZBH on Your Behalf.

Stock Detail Header
  • Street Sentiment
  • Personalized Strategy
  • Free Trading Simulator
Get Started
Stock Details
  • PRICE$122.05
  • PRICE CHANGE$-0.44
  • % CHANGE-0.36%
  • TWEETS3
  • CONSENSUSSTRONG SELL

Trends

Course of Action

STRONG SELL

Sentiment (10 days)

  •  Strong Buy
  •  Buy
  •  Hold
  •  Sell
  •  Strong Sell

DAILY PRICE CHANGE VS SENTIMENT

  • BullishBullish
  • BearishBearish
  • SentimentSentiment
  • BarPrice

What is Robo investing?

Smart Auto-Trading is an advanced Robo-Advisor designed to provides investors with a a state of the art automated trading tool to trade the S&P 500. Its robo is designed to screen, monitor and auto-trade elite stocks like ZIMMER BIOMET HOLDINGS (ZBH). It's Artificial Intelligence augments your potential for profit while eliminating most of the work traditionally involved in trading stocks.

What is Smart Auto-Trading good for?

If you are interested in systematic, active investing, Smart Auto-Trading can be a great alternative to passive index funds and ETFs. Smart Auto-Trading uses Artificial Intelligence concepts to screen, monitor and auto-trade stocks. Used in a tax-deferred account such as an IRA, SIMPLE IRA, Rollover IRA, Keogh, 529 College Plan or UGMA it auto-trades systematically using your carefully defined strategy. Using Smart Auto-Trading is like having a professional trader working for you. You turn it on and it just works.

Smart Auto-Trading actively trades the S&P 500 day-in and day-out in your account while you attend more important life events. Because of the systematic nature of Smart Auto-Trading, your account has the potential to grow at a faster rate than if you were to use a passive investment vehicle such as an index fund or ETF. Systematic active trading using Artificial Intelligence holds the potential to grow your account faster.

Using Smart Auto-Trading is Easy

To connect Smart Auto-Trading to your account you will need to open an account with Ally Invest, one of the most trusted broker/dealer in the United States. Ally Invest is the brokerage firm Stock Circles uses to auto-trade. It offers a very competitive price per trade and flawless execution.

To open an account, please go to Ally Invest's account opening page is available at: https://invest.ally.com/ola/

Once the account is open, you are ready to transfer your money into the newly opened account. To do so, you will need to send a copy of your 401K or other account statement to Ally Invest as well as transfer instructions to support@invest.ally.com. Once they receive your instructions, a Customer Support specialist will help you complete the transfer.

After a few business days, the account will be funded and you will be ready to auto-trade using Smart Auto-Trading.

While this is in progress, you might want to test your strategy in simulation mode free of charge at stockcircles.com. Doing so will help you get comfortable with the product's benefits.

Benefits

There are clear benefits associated with using a Robo-Advisor such as Smart Auto-Trading to help you reach your financial goals. Smart Auto-Trading simplifies stock investing down to a few easy steps. It auto-trades for you, using your personalized strategy, while you attend more important life events.

Using Smart Auto-Trading is like having thousands of traders working for you to help you reach your financial goals.

Smart Auto-Trading actively trades which is different from passive investing. The robo is on the lookout, working to maximize your potential every business day of the year. It trades on the news taking advantage of price changes and trends by listening into trader's communications and by validating this information with market data.

Smart Auto-Trading is one of the first robo-advisor to take advantage of Government grade listening technology, Artificial Intelligence, social media and market data natively.

Try Smart Auto-Trading today!

You can test Smart Auto-Trading in simulation mode, risk free, Stock Circles today.

Get started now - and see where active automated trading can take you.

Disclaimer: Past performance may not be indicative of future results. Therefore, you should assume that the future performance of any specific investment, investment strategy (including robo-strategies), or product made in reference directly or indirectly on this website, will be profitable or equal to corresponding indicated performance levels. Robot-Advisors like other investment methods rely on favorable market conditions to provide positive outcomes.

ZIMMER BIOMET HOLDINGS (ZBH) News

Zimmer Biomet Announces FDA Clearance of the Sidus® Stem-Free Shoulder System

A Clinically-Proven and Effective Bone Preserving Solution for Shoulder Arthroplasty

WARSAW, Ind., Jan. 3, 2018 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the Sidus® Stem-Free Shoulder system as a total shoulder arthroplasty solution for patients with good bone stock that have either osteoarthritis, post-traumatic arthrosis, focal avascular necrosis of the humeral head or who had previous surgeries of the shoulder that do not compromise the fixation. The Sidus Stem-Free Shoulder system is designed to anatomically restore a patient's anatomy, preserve bone stock and allow for improved pre to post-operative patient outcomes1,2. The Sidus system will be available in the United States beginning in the First Quarter of 2018.

"The Sidus Stem-Free Shoulder system offers a novel approach to total shoulder arthroplasty requiring minimal bone resection," said Dr. Ryan Krupp, orthopaedic surgeon at Norton Orthopedic Specialists in Louisville, Ky. "The Sidus system is designed to reduce pain and restore range of motion and is clinically proven to help suitable patients."

"The FDA clearance of the Sidus Stem-Free Shoulder system comes at a time when Zimmer Biomet is accelerating the pace of innovation," said Bryan C. Hanson, Zimmer Biomet President and Chief Executive Officer. "We launched Sidus in Europe in 2012 and initiated a clinical study in the U.S. in 2015. During that time, the product has demonstrated strong clinical performance. The addition of the Sidus system to Zimmer Biomet's U.S. portfolio reinforces the Company's leadership in the innovation of shoulder solutions."

Get Started today! - Risk Free

Investors who like ZIMMER BIOMET HOLDINGS (ZBH) also like

Most Talked About Stocks on Stock Circles

Stock Bubbles